CNS Stimulants
broad category of drugs with varied uses
potential for abuse
cause excitement and euphoria
decreased feelings of fatigue
increase motor activity
methylxanthines
proposed mechanisms
increases Ca2+ influx
increase cAMP/cGMP
blockade of adenosine receptors
effects
increased cardiac output
diuresis
decreased gastric pH
therapy
bronchodilation
vasodilation
coronary arteries
potentiates analgesia (NSAIDs)
nicotine
binds to receptors
CNS
ANS
neuromuscular junction
MOA
dose-dependent effect
depolarization → depolarization blockade
causes receptors to fire → then block firing)
actions
high dose cause respiratory paralysis and hypotension
peripheral effects through ANS stimulation
variable
varenicline
chantix
used for smoking cessation
partial agonist
cocaine
inhibits reuptake of monoamines
can lead to dopamine depletion
increase NE and serotonin in the synapse
amphetamine
MOA
increases monoamines at synaptic cleft
MAOI
direct release of intracellular storees
actions
increase dopamine and NE
sympathetic effects
therapeutic uses
ADHD
blocks dopamine reuptake
blocks NE reuptake
narcolepsy
similar mechanism
appetite suppression
phentermine
diethylpropion
controlled substance
adverse effects
CNS
cardiovascular
GI
do not mix with MAO
side effects
vertigo
HTN
insomnia
confusion
potential for addiction
nausea
diarrhea
Methylphenidate
similar to amphetamine
MOA
increase dopamine and NE
adverse effects
predominantly GI
may induce seizures
side effects
vertigo
HTN
insomnia
confusion
potential for addiction
nausea
diarrhea
Modafinil and Armodafinil
narcolepsy
may involve adrenergic and dopaminergic systems
controlled substance